Matches in Wikidata for { <http://www.wikidata.org/entity/Q67683391> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q67683391 description "article scientifique publié en 1991" @default.
- Q67683391 description "artikull shkencor i botuar më 01 shkurt 1991" @default.
- Q67683391 description "artículu científicu espublizáu en febreru de 1991" @default.
- Q67683391 description "im Februar 1991 veröffentlichter wissenschaftlicher Artikel" @default.
- Q67683391 description "scientific article published on 01 February 1991" @default.
- Q67683391 description "wetenschappelijk artikel" @default.
- Q67683391 description "наукова стаття, опублікована в лютому 1991" @default.
- Q67683391 name "Production of a pokeweed antiviral protein (PAP)-containing immunotoxin, B43-PAP, directed against the CD19 human B lineage lymphoid differentiation antigen in highly purified form for human clinical trials" @default.
- Q67683391 name "Production of a pokeweed antiviral protein (PAP)-containing immunotoxin, B43-PAP, directed against the CD19 human B lineage lymphoid differentiation antigen in highly purified form for human clinical trials" @default.
- Q67683391 name "Production of a pokeweed antiviral protein (PAP)-containing immunotoxin, B43-PAP, directed against the CD19 human B lineage lymphoid differentiation antigen in highly purified form for human clinical trials" @default.
- Q67683391 type Item @default.
- Q67683391 label "Production of a pokeweed antiviral protein (PAP)-containing immunotoxin, B43-PAP, directed against the CD19 human B lineage lymphoid differentiation antigen in highly purified form for human clinical trials" @default.
- Q67683391 label "Production of a pokeweed antiviral protein (PAP)-containing immunotoxin, B43-PAP, directed against the CD19 human B lineage lymphoid differentiation antigen in highly purified form for human clinical trials" @default.
- Q67683391 label "Production of a pokeweed antiviral protein (PAP)-containing immunotoxin, B43-PAP, directed against the CD19 human B lineage lymphoid differentiation antigen in highly purified form for human clinical trials" @default.
- Q67683391 prefLabel "Production of a pokeweed antiviral protein (PAP)-containing immunotoxin, B43-PAP, directed against the CD19 human B lineage lymphoid differentiation antigen in highly purified form for human clinical trials" @default.
- Q67683391 prefLabel "Production of a pokeweed antiviral protein (PAP)-containing immunotoxin, B43-PAP, directed against the CD19 human B lineage lymphoid differentiation antigen in highly purified form for human clinical trials" @default.
- Q67683391 prefLabel "Production of a pokeweed antiviral protein (PAP)-containing immunotoxin, B43-PAP, directed against the CD19 human B lineage lymphoid differentiation antigen in highly purified form for human clinical trials" @default.
- Q67683391 P1433 Q67683391-E9249546-F091-4E1F-8444-76BC76077AFD @default.
- Q67683391 P1476 Q67683391-93D43E85-B421-4F76-8B3D-51AEAA874A62 @default.
- Q67683391 P2093 Q67683391-209D74FF-DAF0-4258-88E7-B72866796281 @default.
- Q67683391 P2093 Q67683391-71B4EE1A-D358-4E4D-8213-35D35C8FAD6C @default.
- Q67683391 P2093 Q67683391-B65A589F-4F6C-4056-B123-7A2ED1DEFD68 @default.
- Q67683391 P2093 Q67683391-E60A9163-2B12-4566-B11C-7E5034D67A74 @default.
- Q67683391 P304 Q67683391-3BAAF1C1-DEBE-4102-821D-704AA340265A @default.
- Q67683391 P31 Q67683391-F6E3132A-7619-4D5E-9A59-9A2D6A20FB75 @default.
- Q67683391 P356 Q67683391-474A2243-CEB3-4399-9177-FAD2FA95A754 @default.
- Q67683391 P433 Q67683391-B76B21C5-D097-4BE4-AD51-C1A4569C4952 @default.
- Q67683391 P478 Q67683391-9770E3BC-0D47-48C1-AE24-226DA63FB878 @default.
- Q67683391 P50 Q67683391-D1F35AAA-A86A-45A4-B204-9E5089A69A33 @default.
- Q67683391 P577 Q67683391-FA374F3B-65B7-455C-B319-506C423662F1 @default.
- Q67683391 P698 Q67683391-95334717-DD73-4955-9272-A37EAAC661EE @default.
- Q67683391 P356 0022-1759(91)90009-5 @default.
- Q67683391 P698 1705571 @default.
- Q67683391 P1433 Q15755939 @default.
- Q67683391 P1476 "Production of a pokeweed antiviral protein (PAP)-containing immunotoxin, B43-PAP, directed against the CD19 human B lineage lymphoid differentiation antigen in highly purified form for human clinical trials" @default.
- Q67683391 P2093 "D E Myers" @default.
- Q67683391 P2093 "J D Irvin" @default.
- Q67683391 P2093 "R S Smith" @default.
- Q67683391 P2093 "V M Kuebelbeck" @default.
- Q67683391 P304 "221-237" @default.
- Q67683391 P31 Q13442814 @default.
- Q67683391 P356 "10.1016/0022-1759(91)90009-5" @default.
- Q67683391 P433 "2" @default.
- Q67683391 P478 "136" @default.
- Q67683391 P50 Q89542817 @default.
- Q67683391 P577 "1991-02-01T00:00:00Z" @default.
- Q67683391 P698 "1705571" @default.